Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe history now shows a new latest revision, v3.6.5, added to the list. The previous revision v3.6.4 has been removed from the history.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision label (v3.6.4) was added to the history, replacing the previous v3.6.3 label. This reflects an update to the page's revision metadata rather than changes to the study content.SummaryDifference0.0%

- Check52 days agoChange DetectedThe revision label in the page footer changed to v3.6.3, indicating a minor site build update rather than a content change.SummaryDifference0.0%

- Check59 days agoChange DetectedAn administrative revision entry (v3.6.2) was added to the study history and an older revision (v3.6.0) was removed, reflecting metadata maintenance of the record.SummaryDifference0.2%

- Check74 days agoChange DetectedRecruitment status was updated to no longer looking for participants, indicating enrollment is closed for this study. The record version was updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check81 days agoChange DetectedRevision: v3.5.5 appears as the latest entry on the history page, replacing the previous v3.5.4 entry. The history is updated to reflect the most recent release.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.